Search

everythinglearnresearchcommunity

for

Search:↓

Some alopecia treatments might help treat COVID-19, but more research is needed.

Cepharanthine, a Japanese hair loss drug, shows promise as a COVID-19 treatment but needs more testing.

Certain genes and nutrients like vitamin D, zinc, and omega fatty acids affect COVID-19 severity and infection risk.

More research is needed to understand sex and racial differences in long COVID.

Hydroxychloroquine, nitazoxanide, and ivermectin were similarly effective in treating early COVID-19.

Most severe COVID-19 patients in Mexico experienced long-lasting symptoms that worsened their quality of life.

The COVID-19 pandemic increased the use of teledermatology to treat skin conditions in low-income areas, despite challenges like poor photo quality.

Mice with a virus similar to COVID-19 had skin damage, but a special treatment helped repair it.

COVID-19 may cause temporary hair loss, which usually gets better on its own, but reducing stress and managing health issues might help recovery.

Early treatment of COVID-19-related hair loss is crucial for better outcomes.

COVID-19 can cause hair loss and nail issues, with treatments available for these conditions.

COVID-19 may cause early hair loss similar to classic temporary hair loss, with further research needed.

Blocking enzymes that help the virus enter cells could be a promising way to treat COVID-19.

One-third of COVID-19 patients had long-term symptoms like hair loss and fatigue, with women, older individuals, blood group B, smokers, and those with more virus exposure at higher risk.

COVID-19 may cause temporary hair loss due to direct damage to hair follicles, but it usually gets better on its own.

Early treatment with certain drug combinations improved COVID-19 outcomes and prevented severe disease in males, including those at higher risk.

COVID-19 can cause hair loss, and treatments like PRP and stem cells might help.

Men with male pattern baldness had worse COVID-19 symptoms, but early treatment with certain drugs improved outcomes for all.

The study concluded that different treatments reduced post-COVID symptoms over time and that factors like age, severity, and comorbidities affect symptom risk.

Hormone replacement therapy may lower the risk of severe COVID-19 outcomes in non-immunosuppressed people and male organ transplant recipients.

COVID-19 can cause hair loss, often treated effectively with a combination of supplements and topical treatments.

Many people in Saudi Arabia experienced hair loss after COVID-19, especially women, those treated with antivirals, and those with a history of hair shedding.

COVID-19 can cause skin symptoms that might help spot the virus early, and treatments for it can also affect the skin.

Many COVID-19 survivors continue to experience symptoms like fatigue and concentration problems after recovery, possibly needing rehabilitation.

Kidney transplant patients who had COVID-19 experienced a significant drop in their quality of life due to long-lasting symptoms.

Early treatment improved COVID-19 outcomes, and spironolactone helped reduce risks in females with high androgen levels.

A new vaccine using a porous scaffold boosts immunity and protects against the flu better than traditional methods.

The COVID-19 pandemic led to fewer patient visits, more visits by older adults, an increase in cutaneous T-cell lymphoma cases, and a rise in noncosmetic procedures at a dermatology clinic.

Proxalutamide helps COVID-19 patients get rid of the virus faster and recover quicker.

Testosterone's effects on COVID-19 are unclear and need more research.